孤立性主动脉瓣置换术后新发房颤的远期发生率与复发
该多中心回顾性队列纳入2002-2014年4家医院接受孤立性主动脉瓣置换术且无术前房颤史的患者,生物瓣529例、机械瓣253例,中位随访5.4年。院内新发房颤者出院后房颤风险显著升高(合并队列HR 3.68,95%CI 2.82-4.81),全因死亡风险亦升高。
要点
- 院内新发房颤者出院后房颤风险增加2-4倍(合并HR 3.68)。
- 机械瓣与生物瓣队列中院内新发房颤均与远期全因死亡风险升高相关。
- 生物瓣队列院内新发房颤比例(50.9%)高于机械瓣队列(25.3%)。
核心结论
- 院内新发房颤与机械瓣和生物瓣主动脉瓣置换术后远期房颤风险增加2-4倍及全因死亡风险增加1.6-2.0倍相关。
研究设计与样本
- 多中心回顾性队列研究,4家医院2002-2014年孤立性主动脉瓣置换术患者1073例,排除术前房颤史后纳入生物瓣529例和机械瓣253例,中位随访5.4年(IQR 3.4-8.2)。
主要发现
- 合并队列中333例(42.6%)发生院内新发房颤,250例(32.0%)出院后发生房颤。
- 机械瓣队列64例(25.3%)发生院内新发房颤,74例(29.2%)出院后发生房颤;生物瓣队列269例(50.9%)发生院内新发房颤,176例(33.3%)出院后发生房颤。
- 院内新发房颤者出院后房颤风险合并HR 3.68(95%CI 2.82-4.81,P<.0001);生物瓣HR 4.35(95%CI 3.05-6.22,P<.001),机械瓣HR 2.54(95%CI 1.59-4.03,P<.001)。
- 院内新发房颤者随访期间调整后全因死亡风险:机械瓣HR 2.05(95%CI 1.10-3.82,P=.025),生物瓣HR 1.63(95%CI 1.17-2.28,P=.004)。
临床怎么用
- 对主动脉瓣置换术后院内新发房颤患者应加强出院后房颤监测与远期随访。
- 院内新发房颤可作为远期死亡风险升高的预警标志,需纳入术后风险管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Atrial fibrillation (AF) is a common complication after cardiac surgery. More knowledge is needed about long-term AF recurrence and adverse outcomes related to new-onset AF (NOAF) during the index hospitalization. METHODS: A total of 1073 patients underwent isolated surgical aortic valve replacement at the 4 participating hospitals (2002-2014). After the exclusion of patients with a history of any preoperative AF, the final study population included 529 patients in the bioprosthetic and 253 patients in the mechanical valve prosthesis cohort. Median follow-up time was 5.4 (interquartile range, 3.4-8.2) years in the combined cohort. RESULTS: Altogether 333 (42.6%) patients had in-hospital NOAF and 250 (32.0%) AF after hospital discharge. In the mechanical cohort, 64 (25.3%) experienced in-hospital NOAF and 74 (29.2%) AF after hospital discharge, whereas in the bioprosthetic cohort, 269 (50.9%) patients had in-hospital NOAF and 176 (33.3%) AF after hospital discharge. Patients with NOAF during the index hospital stay had a multifold risk of AF after hospital discharge in the combined cohort (hazard ratio [HR], 3.68; 95% confidence interval [CI], 2.82-4.81; P < .0001) as well as in both cohorts separately (bioprosthetic: HR, 4.35; 95% CI, 3.05-6.22; P < .001; mechanical: HR, 2.54; 95% CI, 1.59-4.03; P < .001). Patients with an in-hospital NOAF also had a significantly higher adjusted risk of death during the follow-up in the mechanical (HR, 2.05; 95% CI, 1.10-3.82; P = .025) and bioprosthetic (HR, 1.63; 95% CI, 1.17-2.28; P = .004) valve prosthesis cohorts. CONCLUSIONS: NOAF during the index hospitalization is associated with a 2- to 4-fold risk of later AF and 1.6- to 2.0-fold risk of all-cause mortality after mechanical and bioprosthetic surgical aortic valve replacement.
引用
- Björn R, Nissinen M, Lehto J, et al. Late incidence and recurrence of new-onset atrial fibrillation after isolated surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2021. PMID: 33934899. doi:10.1016/j.jtcvs.2021.03.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。